Results

Total Results: 2,327 records

Showing results for "response".

1781. AHRQ EPC Program Research Gaps Summary: Women's Health (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
      April 01, 2022 - • Sertraline may improve response, remission, and depression and anxiety symptoms.

1782. Long COVID Models of Care | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/long-covid-models-care/protocol
      June 01, 2023 - COVID-19 Pharmaceutical Treatments Rapid Evidence Product Oct 28, 2022 Antibody Response

1783. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
      March 01, 2010 - hydralazine/isosorbide dinitrate (H-ISDN) combination* VARIABLE GROUP Variable Categorical response

1784. Layout 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
      September 01, 2011 - These categories are useful in examining potential differences in treatment response and prognosis. … 4.0 - Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM) • Composite measures of response … and intra-rater reliability, internal reliability, construct validity, responsiveness (standardized response … The current response criteria of the ACR Pediatric 30, a composite measure that includes articular … The current response criteria of the ACR 10 Pediatric 30 definition of improvement, a composite measure

1785. Distributed Ambulatory Research in Therapeutics Network (DARTNet): Summary Report | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/distributed-network-ambulatory-therapeutics/research
      January 01, 2019 - DARTNet was formed in response to a request for proposals from the Agency for Healthcare Research and … DARTNet was formed in response to a request for proposals from the Agency for Healthcare Research and … Glycemic response to newly initiated diabetes therapies.

1786. Diabetes Mellitus (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
      January 01, 2012 - In November 2011, FDA issued a complete response letter requesting that the company provide two additional … Iluvien and FDA granted Iluvien priority review by the end of summer 2010, but FDA issued a complete response … Alimera Sciences receives complete response letter from FDA for ILUVIEN. [internet].

1787. Treatment of Stage I-III Squamous Cell Anal Cancer | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/anal-cancer-treatment/protocol
      October 01, 2023 - including persistence, recurrence, or relapse) Colostomy-free survival Local control Complete clinical response

1788. Interventions for Substance Use Disorders in Adolescents: A Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/substance-use-disorders-adolescents/protocol
      October 01, 2019 - to evaluate study, patient, and intervention features, (as listed in the KQs) and to evaluate dose-response

1789. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency/protocol
      February 01, 2021 - We will exclude the study if we receive no response from the authors.

1790. Amended Protocol: Maternal and Childhood Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
      October 01, 2020 - The AHRQ Task Order Officer reviewed the EPC response to contract deliverables for adherence to contract

1791. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
      March 22, 2016 - Other factors that may be considered in assessing strength of evidence include dose-response relationship

1792. Treatment of Stage I-III Squamous Cell Anal Cancer (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
      September 26, 2023 - persistence, recurrence, or relapse) ● Colostomy-free survival ● Local control ● Complete clinical response

1793. Research Protocol for Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
      October 02, 2018 - to evaluate study, patient, and intervention features, (as listed in the KQs) and to evaluate dose-response

1794. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
      April 01, 2010 - plan for depression should be documented If a patient with cancer is treated for depression, then response

1795. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
      July 01, 2012 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy

1796. S44 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
      October 01, 2007 - ORIGINAL ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug Evaluations Malcolm Maclure, ScD,* Bruce Carleton, PharmD,† and Sebastian Schneeweiss, MD, ScD‡§¶ Background: Centralized administrative databases enable low-cost pragmatic randomized trials (PRTs) …

1797. preoperative-testing-protocol-130514 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/preoperative-testing_research-protocol.pdf
      May 14, 2013 - preoperative-testing-protocol-130514 Source: www.effectivehealthcare.ahrq.gov Published online: May 14, 2013 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Routine Preoperative Testing: Comparative Effectiveness Review I. Background and Objectives for the Systemat…

1798. pneumonia-antibiotic-treatment-protocol-130718 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
      July 19, 2013 - This target is based upon retrospective clinical data correlating clinical response with specific Cmax … Clinical response or mechanical ventilation? b. Morbidity or mortality? c. … Clinical response or mechanical ventilation? b. Morbidity or mortality? … It also considers other optional domains that may be relevant for some scenarios, such as dose-response … Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal

1799. Osheroff_Respondent_Ebell 2 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/use_of_handheld_osheroff_respondent.pdf
      January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm)     Slide  1:  Ebell/Handheld  Decision  Support:  Osheroff  Response

1800. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
      November 22, 2011 - There are currently two basic approaches for trying to determine whether a patient will have a poor response … is taking clopidogrel to see whether the platelets actually have become less prone to aggregate in response … all other reviews reached favorable conclusions regarding the use of CYP2C19 genetic testing for response … Clinical implications of clopidogrel non- response in cardiovascular patients: a systematic review and … System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human